Income Statement (PARATEK/PHARMA)

PARATEK/PHARMA NEWS

Nontuberculous Mycobacteria (NTM) Opportunity Assessment and Forecast to 2033 Featuring Janssen, Novartis, Meiji Seika Pharma, Insmed, Daiichi Sankyo, MannKind, Paratek, Nobelpharma, GSK, Pfizer By Research - 1 month ago

Dublin, July 17, 2025 (GLOBE NEWSWIRE) -- The "Nontuberculous Mycobacteria (NTM): Opportunity Assessment and Forecast" report has been added to ResearchAndMarkets.com's offering. The report provides… [+5093 chars]...

Read more
Neuronetics Appoints New Chief Financial Officer By Neuronetics - 1 month ago

Steven Pfanstiel, a seasoned financial executive with extensive medical technology and pharmaceutical experience, replaces Steve Furlong as Chief Financial Officer following previously announced succ… [+10612 chars]...

Read more
Top Stock
CurrencyPrice Chg
BA
232.47 -2.79
-1.19%
CVX
155.32 -1.23
-0.79%
CAT
412.64 4.85
1.19%
INTC
23.64 -0.92
-3.75%
MSFT
517.14 -3.03
-0.58%
DIS
116.55 1.16
1.01%
DOW
23.24 -0.12
-0.51%
CSCO
66.95 0.75
1.13%
GS
730.96 0.24
0.03%